New combo therapy targets Hard-to-Treat prostate cancer
NCT ID NCT04946370
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 32 times
Summary
This study tests whether adding a targeted radiation drug (225Ac-J591) to standard immunotherapy (pembrolizumab) and hormone therapy works better for men with advanced prostate cancer that has spread and stopped responding to treatment. About 52 men will participate. The goal is to see if the combination shrinks tumors, lowers PSA levels, and improves survival, while monitoring side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Cancer Center
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dana-Farber Cancer Institute
NOT_YET_RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
New York Presbyterian/Brooklyn Methodist Hospital
RECRUITINGBrooklyn, New York, 11215, United States
Contact
-
New York Presbyterian/Weill Cornell Medical Center
RECRUITINGNew York, New York, 10021, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.